Quibim says its longer-term plan is to create digital twins of the entire human body, serving “dynamic models” that help the ...

JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR") announced today that it will present at the 21st Annual WORLDSymposiumtm 2025, held February 3-7, 2025, in San Diego, Calif. The poster presentations ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

The company revealed plans to increase the usage of AI in pharma at JP Morgan’s healthcare conference in San Francisco. Over the past two years, the life sciences industry has seemingly fully embraced ...

Integrating AI tools into drug discovery introduces a mix of opportunities and challenges for startups and large pharmaceutical companies. These challenges often center on intellectual property ...

Boston, MA – RE•WORK is excited to announce the AI in Healthcare & Pharma Summit 2025, taking place on November 18-19, 2025, in Boston, MA. This premier event will bring together healthcare ...

These characteristics make neuro-symbolic AI an exciting prospect for many demanding business applications. Pharmaceutical leaders are among those examining the best ways to use it. How can this ...

Rajeev Chadha, Vice President and Country Manager for India at Planview, delves into how Planview is integrating Artificial Intelligence to revolutionize project management and strategic planning.

Survey finds AI to enhance productivity and cut costs in the next 12 months AI is poised to significantly lower pharmaceutical R&D costs through efficient drug discovery, optimised clinical trials, ...